Biogen (BIIB)

Cash & Short-Term Investments

$1.29B

Quarterly · Period ending: · USD

BIIB logo

BIIB Cash & Short-Term Investments

Latest reported$1.29B
BIIB Quarterly Cash & Short-Term Investments ($53.50M → $1.29B)
High-resolution chart · PNG

BIIB cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
759,996,000
635,863,000
682,412,000
659,034,000
652,187,000
668,830,000
654,539,000
672,600,000
52,700,000
91,400,000
516,914,000
94,200,000
71,800,000
65,600,000
440,088,000
62,600,000
73,300,000
101,500,000
321,381,000
62,600,000
50,100,000
32,500,000
307,948,000
52,500,000
46,700,000
68,400,000
267,802,000
65,500,000
39,100,000
52,700,000
74,500,000
74,900,000
77,200,000
47,400,000
85,900,000
75,400,000
36,800,000
38,800,000
56,600,000
20,400,000
3,500,000
17,100,000
12,600,000
14,500,000
17,200,000
14,300,000
33,200,000
32,300,000
54,300,000
54,400,000
70,500,000
53,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.